Amedisys (AMED) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Income before income taxes: 18.19M
Today's EPS Names:
SFNC, CSBR, MAN, More
Financial Fact:
Income before income taxes: 18.19M
Today's EPS Names:
SFNC, CSBR, MAN, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $314.2 million versus the consensus estimate of $307.11 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- Nomura/Instinet Resumes Pan Pacific International Holdings Corp (7532:JP) (DQJCY) at Buy
- Stifel Downgrades Pentair (PNR) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
